Frontiers in Oncology | Thoracic Oncology

Case Report

Published on 09 Oct 2023

Selpercatinib and capmatinib combination promotes sustained complete response in novel ISOC1-RET fusion lung cancer after resistance to RET inhibitor via MET amplification: Case Report

in Thoracic Oncology

Caio Abner Leite
Raíssa Pierri Carvalho
Felipe Marques da Costa
Augusto Kreling Medeiros
Fabio Augusto Schutz
William Nassib William

Frontiers in Oncology

doi 10.3389/fonc.2023.1264231

3,252 views
9 citations

Original Research

Published on 05 Oct 2023

A plasma miRNA-based classifier for small cell lung cancer diagnosis

in Thoracic Oncology

Michela Saviana
Giulia Romano
Joseph McElroy
Giovanni Nigita
Rosario Distefano
Robin Toft
Federica Calore
Patricia Le
Daniel Del Valle Morales
Sarah Atmajoana

Frontiers in Oncology

doi 10.3389/fonc.2023.1255527

3,904 views
9 citations

Systematic Review

Published on 04 Oct 2023

Association of Epstein-Barr virus (EBV) with lung cancer: meta-analysis

in Thoracic Oncology

Yizhuo Chen
Tianhua Liu
Ziqing Xu
Ming Dong

Frontiers in Oncology

doi 10.3389/fonc.2023.1177521

5,690 views
11 citations

Case Report

Published on 04 Oct 2023

A rare case report: co-occurrence of two types of lung cancer with hamartoma and pulmonary tuberculosis

in Thoracic Oncology

Jianxiong Kang
Mu Wang
Peiyan Hua
Bin Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1264871

2,858 views

Original Research

Published on 04 Oct 2023

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic

in Thoracic Oncology

Zoltán Kiss
Gabriella Gálffy
Veronika Müller
Judit Moldvay
Veronika Sárosi
Zsolt Pápai-Székely
Edit Csada
Anna Kerpel-Fronius
Zsolt Király
Zoltán Szász

Frontiers in Oncology

doi 10.3389/fonc.2023.1207295

4,173 views
8 citations

Systematic Review

Published on 04 Oct 2023

Comparison of lobectomy and sublobar resection for stage I non-small cell lung cancer: a meta-analysis based on randomized controlled trials

in Thoracic Oncology

Genlin Lu
Zhiyi Xiang
Yan Zhou
Senjie Dai
Fei Tong
Renya Jiang
Min Dai
Qiufeng Zhang
Difeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1261263

3,042 views
3 citations

Original Research

Published on 03 Oct 2023

Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors

in Thoracic Oncology

Ping-Chih Hsu
Chun-Yao Huang
Yu-Ching Lin
Suey-Haur Lee
Li-Chung Chiu
Chiao-En Wu
Scott Chih-Hsi Kuo
Jia-Shiuan Ju
Allen Chung-Cheng Huang
Ho-Wen Ko

Frontiers in Oncology

doi 10.3389/fonc.2023.1249106

2,550 views
1 citation

Original Research

Published on 28 Sep 2023

Donor/recipient origin of lung cancer after lung transplantation by DNA short tandem repeat analysis

in Thoracic Oncology

Julien De Wolf
Edouard Robin
Alexandre Vallee
Justine Cohen
Abdul Hamid
Antoine Roux
Morgan Leguen
Romane Beaurepere
Ivan Bieche
Julien Masliah-Planchon

Frontiers in Oncology

doi 10.3389/fonc.2023.1225538

2,964 views

Case Report

Published on 26 Sep 2023

Recurrence of solitary fibrous tumor of the pleura with hypoglycemia (Doege–Potter Syndrome): a case report description

in Thoracic Oncology

Chuxu Wang
Tingting Cao
Guodong Hu
Bo Min
Haibo Hu
Bing Liu
Yaqin Wang
Xiaohua Zuo

Frontiers in Oncology

doi 10.3389/fonc.2023.1245289

2,128 views
6 citations

Review

Published on 25 Sep 2023

Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions

in Thoracic Oncology

Priyanka Sahu
Chantal Donovan
Keshav Raj Paudel
Sophie Pickles
Vrushali Chimankar
Richard Y. Kim
Jay C. Horvart
Kamal Dua
Antonio Ieni
Francesco Nucera

Frontiers in Oncology

doi 10.3389/fonc.2023.1260411

6,154 views
14 citations

Original Research

Published on 22 Sep 2023

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer

in Thoracic Oncology

Friederike C. Althoff
Lisa V. Schäfer
Fabian Acker
Lukas Aguinarte
Sophie Heinzen
Maximilian Rost
Akin Atmaca
Vivian Rosery
Jürgen Alt
Cornelius F. Waller

Frontiers in Oncology

doi 10.3389/fonc.2023.1273478

3,209 views

Editorial

Published on 21 Sep 2023

Editorial: Editor's challenge: Dr. Luciano Mutti - what is the true impact of ICIs on survival in the treatment of thoracic malignancies?

in Thoracic Oncology

Luciano Mutti
Steven G. Gray

Frontiers in Oncology

doi 10.3389/fonc.2023.1285031

1,509 views

Case Report

Published on 20 Sep 2023

Malignant lung PEComa (clear cell tumor): rare case report and literature review

in Thoracic Oncology

Marcos Adriano Garcia Campos
Lucas Fernandes Vasques
Rafael Goulart de Medeiros
Érico Murilo Monteiro Cutrim
Ana Júlia Favarin
Sarah Rebecca Machado Silva
Gyl Eanes Barros Silva
Marcelo Padovani de Toledo Moraes
Mariana Lopes Zanatta
Diego Aparecido Rios Queiróz

Frontiers in Oncology

doi 10.3389/fonc.2023.1260844

3,750 views
6 citations

Original Research

Published on 20 Sep 2023

The presence of autoantibodies is associated with improved overall survival in lung cancer patients

in Thoracic Oncology

Keying Jing
Huijuan Zhao
Jun Cai
Lianlian Chen
Peiming Zheng
Libo Ouyang
Gang Li
Rong Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1234847

2,957 views
5 citations

Original Research

Published on 18 Sep 2023

Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort study

in Thoracic Oncology

David E. Dawe
Rebekah Rittberg
Iqra Syed
Mary Kate Shanahan
Daniel Moldaver
Oliver Bucher
Katie Galloway
Kayla Reynolds
James T. Paul
Craig Harlos

Frontiers in Oncology

doi 10.3389/fonc.2023.1191855

6,036 views
5 citations

Original Research

Published on 18 Sep 2023

Nomogram combining clinical and radiological characteristics for predicting the malignant probability of solitary pulmonary nodules measuring ≤ 2 cm

in Thoracic Oncology

Mengchao Xue
Rongyang Li
Kun Wang
Wen Liu
Junjie Liu
Zhenyi Li
Zheng Ma
Huiying Zhang
Hui Tian
Yu Tian

Frontiers in Oncology

doi 10.3389/fonc.2023.1196778

2,686 views
5 citations

Case Report

Published on 14 Sep 2023

Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous cell lung cancer: a case report and literatures review

in Thoracic Oncology

Zhiqin Zhang
Jiamao Lin
Linke Yang
Yang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1188772

2,998 views
2 citations

Original Research

Published on 14 Sep 2023

Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China

in Thoracic Oncology

Mengting Chen
Huiqing Yu
Liejun Yang
Hong Yang
Haoyang Cao
Lei Lei
Liling Ma
Shihong Liu
Ling Tian
Sixiong Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1184961

5,478 views
13 citations

Original Research

Published on 12 Sep 2023

Genomic profiling and sites of metastasis in non-small cell lung cancer

in Thoracic Oncology

Kok Hoe Chan
Arthi Sridhar
Ji Zheng Lin
Syed Hassan Raza Jafri

Frontiers in Oncology

doi 10.3389/fonc.2023.1212788

3,457 views
8 citations

Original Research

Published on 11 Sep 2023

Risk factor analysis for major mediastinal vessel invasion in thymic epithelial tumors based on multi-slice CT Imaging

in Thoracic Oncology

Yu-Hui Ma
Jie Zhang
Wei-Qiang Yan
Jiang-Tao Lan
Xiu-Long Feng
Shu-Mei Wang
Guang Yang
Yu-Chuan Hu
Guang-Bin Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1239419

1,946 views

Original Research

Published on 11 Sep 2023

Almonertinib plus chemotherapy versus almonertinib alone in second-line treatment of advanced non-small cell lung cancer with mutated epidermal growth factor receptor: a retrospective study

in Thoracic Oncology

Xiaoxu Fang
Yan Xiang
Kaihua Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1248690

2,625 views
2 citations

Editorial

Published on 08 Sep 2023

Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer

in Thoracic Oncology

Taiseer Al-Rajabi
Jarushka Naidoo
Jun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1277542

1,763 views

Original Research

Published on 06 Sep 2023

Right upper lobe segmentectomy and subsegmentectomy guided by classification pattern of peripheral segmental veins

in Thoracic Oncology

Zhikai Li
Shuangqing Chen
Dahu Ren
Yuhong Kong
Shun Xu
Guochen Duan
Xiaopeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1179570

2,241 views
1 citation

Mini Review

Published on 06 Sep 2023

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer

in Thoracic Oncology

Xiaoli Liu
Alexander Chi

Frontiers in Oncology

doi 10.3389/fonc.2023.1211815

8,448 views
12 citations

1,929 articles

articles

Selpercatinib and capmatinib combination promotes sustained complete response in novel ISOC1-RET fusion lung cancer after resistance to RET inhibitor via MET amplification: Case Report

A plasma miRNA-based classifier for small cell lung cancer diagnosis

Association of Epstein-Barr virus (EBV) with lung cancer: meta-analysis

A rare case report: co-occurrence of two types of lung cancer with hamartoma and pulmonary tuberculosis

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic

Comparison of lobectomy and sublobar resection for stage I non-small cell lung cancer: a meta-analysis based on randomized controlled trials

Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors

Donor/recipient origin of lung cancer after lung transplantation by DNA short tandem repeat analysis

Recurrence of solitary fibrous tumor of the pleura with hypoglycemia (Doege–Potter Syndrome): a case report description

Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer

Editorial: Editor's challenge: Dr. Luciano Mutti - what is the true impact of ICIs on survival in the treatment of thoracic malignancies?

Malignant lung PEComa (clear cell tumor): rare case report and literature review

The presence of autoantibodies is associated with improved overall survival in lung cancer patients

Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort study

Nomogram combining clinical and radiological characteristics for predicting the malignant probability of solitary pulmonary nodules measuring ≤ 2 cm

Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous cell lung cancer: a case report and literatures review

Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China

Genomic profiling and sites of metastasis in non-small cell lung cancer

Risk factor analysis for major mediastinal vessel invasion in thymic epithelial tumors based on multi-slice CT Imaging

Almonertinib plus chemotherapy versus almonertinib alone in second-line treatment of advanced non-small cell lung cancer with mutated epidermal growth factor receptor: a retrospective study

Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer

Right upper lobe segmentectomy and subsegmentectomy guided by classification pattern of peripheral segmental veins

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer